A bucket containing a soupy green mixture sits under a table in Nduna Ewrong-Nxumalo's consultation room in downtown Johannesburg, South Africa's economic hub.
All news from Forensic Medicine & Toxicology
In the Cellular Immunotherapy and Transplantation Program at Virginia Commonwealth University Massey Cancer Center, scientists are pursuing a cross-collaborative effort that could potentially change the way cellular immunotherapies such as stem cell transplantation and CAR T-cell therapies are performed.
University of Minnesota Medical School researchers seeks to identify the relationship between insurance coverage and the mortality rate of patients transferred between hospitals.
Women with breast implants mostly only had to worry about leaks, but a large-scale Israeli study performed in collaboration with researchers from the University of Alberta confirmed almost one in four implantation patients is at risk of a serious autoimmune disorder.
Stanford University School of Medicine scientists have developed a noninvasive way of delivering drugs to within a few millimeters of a desired point in the brain. The method, tested in rats, uses focused ultrasound to jiggle drug molecules lose from nanoparticle "cages" that have been injected into the bloodstream.
Elevated levels of trimethylamine N-oxide (TMAO)–a compound linked with the consumption of fish, seafood and a primarily vegetarian diet–may reduce hypertension-related heart disease symptoms.
A research team led by Dr. Xiang David Li from the Department of Chemistry at The University of Hong Kong (HKU), in collaboration with scientists from Tsinghua University in China, The Rockefeller University, and The University of Texas in the United States, developed the first chemical inhibitors against a novel therapeutic target for treatment of acute myeloid leukemia (AML), a fast-growing cancer of bone marrow and blood cells.
What are the goals of healthcare? That very question must be asked more frequently before healthcare-related choices are made. This is what Martine de Vries, Professor of Normative Aspects of Medicine, advocated during her inaugural lecture on Friday, 2 November 2018.
Currently, the only therapy for a metabolic liver disease is an organ transplant. Tracy Grikscheit, MD, an attending physician and regenerative medicine scientist at Children's Hospital Los Angeles, hopes to change that reality.